PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial...

  1. Hot News
    193,285 Posts.
    lightbulb Created with Sketch. 2822
    clock Created with Sketch.
    19/12/22
    10:20
    Post #: 65363435

    Dec 19 (Reuters) - Antisense Therapeutics Ltd (ANP) :

    • CLINICAL TRIAL APPLICATION SUBMITTED FOR ATL1102 PHASE IIB DMD TRIAL CONDUCT IN EUROPE
    • CTA APPROVALS ARE EXPECTED TO COME THROUGH IN A STAGGERED MANNER IN EARLY 2023
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $16.86K 210.8K

Buyers (Bids)

No. Vol. Price($)
3 129844 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 65906 3
View Market Depth
Last trade - 15.05pm 22/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.